Target intelligence / Profile preview

Syntaxin-7 (STX7)

Target
STX7
Molecular classification
SNARE protein, Membrane trafficking protein, Vesicle fusion protein
01

Overview

Syntaxin-7 is a membrane SNARE protein of the syntaxin family encoded by the STX7 gene. It mediates endosomal trafficking, including homotypic fusion of late endosomes and heterotypic fusion with lysosomes. Syntaxin-7 forms complexes with other SNARE proteins, including STX8, Vti1b, VAMP7, and VAMP8, and is essential for proper cargo delivery and membrane dynamics. It modulates invadopodia formation and extracellular matrix degradation in cancer cells, facilitating invasion, and also contributes to synaptic vesicle recycling in neurons during high-frequency stimulation[1][2][4][5]. Syntaxin-7 interacts with proteins such as alpha-SNAP, STX8, VAMP7/VAMP8, SNAP23, VAMP2, VAMP3, VPS18, and VPS11, highlighting its complex regulation in vesicular compartments[1][3][5]. Syntaxin-7 is best classified as a membrane trafficking SNARE essential for vesicle fusion and cellular invasion processes, with emerging relevance in cancer biology and neurobiology[1][2][4][5].

Other names
STX7Syntaxin 7syntaxin-7
02

Mechanism of action

N/A; no approved drugs or clinical candidates directly target Syntaxin-7. Experimental evidence shows that altering STX7 function can affect cancer cell invasion and synaptic vesicle replenishment, but this involves genetic or protein-level modulation rather than small-molecule or antibody drugs

03

Biological functions

Vesicle transport and traffickingEndosome-lysosome fusionProtein trafficking from plasma membrane to early endosomeSynaptic vesicle replenishment during high-frequency stimulation in neuronsInvadopodia formation and cancer cell invasion
04

Disease associations

Cancer (e.g. breast cancer cell invasion)Hemophagocytic lymphohistiocytosisIntracranial vasospasmNeurobiology (synaptic transmission modulation)
05

Safety considerations

There are no documented safety concerns directly related to targeting Syntaxin-7; however, because it regulates essential trafficking pathways in multiple cell types, non-specific inhibition may risk interfering with vital intracellular processes and synaptic transmission

Beyond the preview

Go deeper on Syntaxin-7 (STX7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syntaxin-7 (STX7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call